Advanced Medical Solutions Group Plc · LSE:AMS
Advanced Medical Solutions — Shareholder Meeting (June 2017)
8 slides from Advanced Medical Solutions's shareholder meeting presentation, Jun 7, 2017
Slide 1: Annual General Meeting June 7th 2017
Advanced Medical Solutions Group plc Annual General Meeting June 7th 2017 Christopher Meredith Chief Executive Officer
Slide 2: 2016 Business Highlights
Advanced Medical Solutions Group plc 1 2016 Business Highlights • Good sales progress across all Business Units • Continued strong performance in the US with LiquiBand® tissue adhesive range: • Revenues up 39% to £12.5 million • Market share increased to 23% • Successful launch of antimicrobial and
Slide 3: Sales channels and revenue by AMS Group business
Advanced Medical Solutions Group plc 2 Sales of AMS Group brands: LiquiBand® Revenue Branded Quality outcomes Distributed and RESORBA®, through our global network of distributors. £20.8m • Global network of >100 distribution S partners (incl. Russia) +30% Protecting patients u r Own brand g i produc
Slide 4: Branded Distributed 2016
Advanced Medical Solutions Group plc 3 Branded Distributed 2016 Revenue up 30% to £20.8 million (2015: £14.6 million) • LiquiBand® • US sales up 39% to £12.5 million • Market share up to 23% & targeting a minimum 30% share by 2019 • EU and ROW sales up 28% • Sales up in Asia Pacific through distribu
Slide 5: Branded Direct: 2016
Advanced Medical Solutions Group plc 4 Branded Direct: 2016 Revenue up 3% to £24.6 million (2015: £22.3 million) • LiquiBand® • UK OR sales up 31% to £0.9 million • Germany and Czech Republic sales up 8% to £1.7 million • LiquiBand® Fix8™ up 69% to £0.6m • RESORBA® • Germany and Czech Republic sales
Slide 6: OEM: 2016
Advanced Medical Solutions Group plc 5 OEM: 2016 Revenue up 12% to £32.1 million (2015: £27.7 million) • Successful launch of new foam dressing range • Antimicrobial foam range (PHMB) and atraumatic foam range (silicone) both launched in Europe • PHMB US approval process underway with expected launc
Slide 7: 2016 Financial Highlights
Advanced Medical Solutions Group plc 6 2016 Financial Highlights Reported Constant 2016 2015 growth growth Group revenue (£m) 82.6 68.6 20% 13% Adjusted operating margin (%) 23.9 25.4 (150bps) Adjusted profit before tax (£m) 19.7 17.4 13% Profit before tax (£m) 19.1 17.0 12% Adjusted diluted earning
Slide 8: Summary & Outlook
Advanced Medical Solutions Group plc 7 Summary & Outlook • 13% revenue growth with good profitability and cash generation • All Business Units have delivered a strong performance • Very strong US Liquiband performance with 23% market share and targeting to reach 30% in next 3 years • Continued succe
Advanced Medical Solutions Group — Shareholder Meeting (June 2017) on 6ix